GB202108302D0 - New treatment - Google Patents

New treatment

Info

Publication number
GB202108302D0
GB202108302D0 GBGB2108302.7A GB202108302A GB202108302D0 GB 202108302 D0 GB202108302 D0 GB 202108302D0 GB 202108302 A GB202108302 A GB 202108302A GB 202108302 D0 GB202108302 D0 GB 202108302D0
Authority
GB
United Kingdom
Prior art keywords
new treatment
treatment
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2108302.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Natco Pharma Ltd
Original Assignee
Natco Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natco Pharma Ltd filed Critical Natco Pharma Ltd
Priority to GBGB2108302.7A priority Critical patent/GB202108302D0/en
Publication of GB202108302D0 publication Critical patent/GB202108302D0/en
Priority to IL309181A priority patent/IL309181A/en
Priority to CN202280042824.8A priority patent/CN117545476A/en
Priority to BR112023025903A priority patent/BR112023025903A2/en
Priority to KR1020247000892A priority patent/KR20240021237A/en
Priority to AU2022291015A priority patent/AU2022291015A1/en
Priority to PCT/GB2022/051450 priority patent/WO2022258977A1/en
Priority to EP22732626.1A priority patent/EP4337191A1/en
Priority to CA3221808A priority patent/CA3221808A1/en
Ceased legal-status Critical Current

Links

GBGB2108302.7A 2021-06-10 2021-06-10 New treatment Ceased GB202108302D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB2108302.7A GB202108302D0 (en) 2021-06-10 2021-06-10 New treatment
IL309181A IL309181A (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer
CN202280042824.8A CN117545476A (en) 2021-06-10 2022-06-09 EGFR inhibitors for the treatment of head and neck cancer
BR112023025903A BR112023025903A2 (en) 2021-06-10 2022-06-09 COMPOUND FOR USE IN THE TREATMENT OF SQUAMOUS CELL CARCINOMA, COMPOUND FOR USE IN THE TREATMENT OF HEAD AND NECK CANCER, METHODS FOR TREATING SQUAMOUS CELL CARCINOMA AND FOR TREATING HEAD AND NECK CANCER AND USES OF A COMPOUND
KR1020247000892A KR20240021237A (en) 2021-06-10 2022-06-09 EGFR inhibitors for head and neck cancer treatment
AU2022291015A AU2022291015A1 (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer
PCT/GB2022/051450 WO2022258977A1 (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer
EP22732626.1A EP4337191A1 (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer
CA3221808A CA3221808A1 (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2108302.7A GB202108302D0 (en) 2021-06-10 2021-06-10 New treatment

Publications (1)

Publication Number Publication Date
GB202108302D0 true GB202108302D0 (en) 2021-07-28

Family

ID=76954593

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2108302.7A Ceased GB202108302D0 (en) 2021-06-10 2021-06-10 New treatment

Country Status (2)

Country Link
CN (1) CN117545476A (en)
GB (1) GB202108302D0 (en)

Also Published As

Publication number Publication date
CN117545476A (en) 2024-02-09

Similar Documents

Publication Publication Date Title
GB202108224D0 (en) Treatment
GB202016058D0 (en) Therapeautic treatment
GB202003722D0 (en) Treatment
GB202002711D0 (en) Treatment
GB202108302D0 (en) New treatment
GB202108300D0 (en) New treatment
GB202006236D0 (en) New treatment
GB202116743D0 (en) Treatment
GB202114373D0 (en) Treatment
GB202109815D0 (en) Treatment
GB202109812D0 (en) Treatment
GB202104666D0 (en) COVID-19 treatment
GB202104416D0 (en) Treatment reginmens
GB202103957D0 (en) Treatment
GB202103122D0 (en) Treatment
GB202102488D0 (en) Treatment
GB202102369D0 (en) Treatment
GB202102410D0 (en) Treatment
GB202102366D0 (en) Treatment
GB202102373D0 (en) Treatment
GB202101897D0 (en) Treatment
GB202101875D0 (en) Treatment
GB202101213D0 (en) Treatment
GB202101211D0 (en) Treatment
GB202101212D0 (en) Treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)